Inhaled iloprost administered to children with pulmonary arterial hypertension (PAH) was shown to be safe and effective in a new study from the University of Colorado/Children's Hospital and Texas Children's Hospital. Eleven children with PAH were treated with inhaled iloprost five to nine times daily, for 3 to 11 months. Researchers compared pretreatment responses with iloprost vs inhaled nitric oxide during cardiac catheterization. [click link for full article]
(more...)